ZARNESTRALINE Trademark

Trademark Overview

On Thursday, December 23, 2004, a trademark application was filed for ZARNESTRALINE with the United States Patent and Trademark Office. The USPTO has given the ZARNESTRALINE trademark a serial number of 78537819. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, July 18, 2008. This trademark is owned by Johnson & Johnson. The ZARNESTRALINE trademark is filed in the Advertising, Business and Retail Services category with the following description:

PATIENT ASSISTANCE PROGRAM THAT PROVIDES INFORMATION REGARDING DRUG COST REIMBURSEMENT AND SUPPORT
zarnestraline

General Information

Serial Number78537819
Word MarkZARNESTRALINE
Filing DateThursday, December 23, 2004
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateFriday, July 18, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2005

Trademark Statements

Goods and ServicesPATIENT ASSISTANCE PROGRAM THAT PROVIDES INFORMATION REGARDING DRUG COST REIMBURSEMENT AND SUPPORT

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, August 5, 2005
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001
Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001

Trademark Events

Event DateEvent Description
Thursday, September 18, 2008ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Thursday, September 18, 2008ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 12, 2008EXTENSION 4 GRANTED
Wednesday, January 16, 2008EXTENSION 4 FILED
Wednesday, January 16, 2008PAPER RECEIVED
Monday, July 16, 2007EXTENSION 3 GRANTED
Monday, July 16, 2007EXTENSION 3 FILED
Monday, July 16, 2007TEAS EXTENSION RECEIVED
Wednesday, January 17, 2007EXTENSION 2 GRANTED
Wednesday, January 17, 2007EXTENSION 2 FILED
Wednesday, January 17, 2007TEAS EXTENSION RECEIVED
Friday, July 14, 2006EXTENSION 1 GRANTED
Friday, July 14, 2006EXTENSION 1 FILED
Friday, July 14, 2006TEAS EXTENSION RECEIVED
Tuesday, January 17, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 25, 2005PUBLISHED FOR OPPOSITION
Wednesday, October 5, 2005NOTICE OF PUBLICATION
Thursday, August 25, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 19, 2005ASSIGNED TO LIE
Tuesday, August 16, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 5, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 28, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 28, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 28, 2005NON-FINAL ACTION MAILED
Thursday, January 27, 2005NON-FINAL ACTION WRITTEN
Wednesday, January 26, 2005ASSIGNED TO EXAMINER
Friday, January 7, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

zarnestraline drug cost reimbursement support regarding information assistance program provides patient